v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

TENELIGLIPTIN INDUCED PERSISTENT DIARRHEA

AUTHORS:

Sheba Susan Chacko*, Josna James, Nigel V Sailesh, Jency Maria Koshy

ABSTRACT:

Teneligliptin is an Oral hypoglycemic agent (OHA) widely used for the treatment of Type 2 Diabetes Mellitus in adults. Rare side effects such as hypoglycemia, diarrhea, loss of appetite and abdominal distress have been noted with the usage of Teneligliptin. Here we report the case of a 65-year-old man diagnosed with Type 2 Diabetes Mellitus who developed profuse diarrhea and significant weight loss following intake of Teneligliptin. Key Words: Teneligliptin, Type2 Diabetes Mellitus, Diarrhea

FULL TEXT

Download PDF

<
Approved Journal



CLICK HERE
NLM ID:101711216 [Serial]



CAS Source Index (CASSI) Search Tool
Included in EuroPub database



CAS Source Index (CASSI) Search Tool
ICV 2015 - 61.16



CAS Source Index (CASSI) Search Tool
Indexed In



CAS Source Index (CASSI) Search Tool
S.J Impact Factor:7.157



impact factor
cosmos Impact Factor:4.153



impact factor
ICMJE Recommendations



CAS Source Index (CASSI) Search Tool
IP Indexing Impact Factor: 2.76



CAS Source Index (CASSI) Search Tool
Cover Page
Cover Page
© 2014 Indo American Journal of Pharmaceutical Sciences(IAJPS) All Rights Reserved.
Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.